Status: Not yet recruiting
Aciclovir Versus Placebo for HSV-2 Meningitis
To determine whether active treatment with (val)acyclovir is superior for treatment of viral meningitis compared with placebo assessed by numbers meeting a primary, objective endpoint at 7 days after randomisation
Participants needed: 150
Trial details
Phase: Phase 4Biological sex: AllType: InterventionalSponsor: Jacob BodilsenUpdated: Oct 1, 2025
Eligibility criteria
A clinical presentation consistent with viral meningitis (e.g. headache, nuchal... [+4]
Encephalitis as defined by the International Encephalitis Consortium if diagnose... [+10]